The tumor microenvironment as driver of stemness and therapeutic resistance in breast cancer: New challenges and therapeutic opportunities

被引:0
作者
Umar Mehraj
Rais A. Ganai
Muzafar A. Macha
Abid Hamid
Mohammed A. Zargar
Ajaz A. Bhat
Mohd Wasim Nasser
Mohammad Haris
Surinder K. Batra
Bader Alshehri
Raid Saleem Al-Baradie
Manzoor A. Mir
Nissar Ahmad Wani
机构
[1] University of Kashmir,Department of Bioresources
[2] Islamic University of Science & Technology ,Watson
[3] Central University of Kashmir,Crick Centre for Molecular Medicine
[4] Sidra Medicine,Department of Biotechnology, School of Life Sciences
[5] University of Nebraska Medical Center,Translational Medicine, Research Branch
[6] Qatar University,Department of Biochemistry and Molecular Biology
[7] Eppley Institute for Research in Cancer and Allied Diseases,Laboratory of Animal Research
[8] University of Nebraska,Buffett Cancer Center
[9] University of Nebraska Medical Center,Department of Medical Laboratory Sciences, College of Applied Medical Sciences
[10] Majmaah University,undefined
来源
Cellular Oncology | 2021年 / 44卷
关键词
Breast cancer; Tumor microenvironment; Targeted therapeutics; Cancer-associated fibroblasts; Tumor-associated macrophages; Immunotherapy; Cancer stemness;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1209 / 1229
页数:20
相关论文
共 622 条
[61]  
Podgorski I(2014)Hyaluronan synthases (HAS1–3) in stromal and malignant cells correlate with breast cancer grade and predict patient survival Breast Cancer Res. Treat. 143 1270-706
[62]  
Sloane BF(2020)The dynamic relationship of breast cancer cells and fibroblasts in fibronectin accumulation at primary and metastatic tumor sites Cancers 12 6463-3809
[63]  
Choi YP(2011)Pivotal role of reduced let-7g expression in breast cancer invasion and metastasis Can. Res. 71 1-160
[64]  
Lee JH(2018)Matrix stiffness-upregulated LOXL2 promotes fibronectin production, MMP9 and CXCL12 expression and BMDCs recruitment to assist pre-metastatic niche formation J. Exp. Clin. Cancer Res. 37 270-3579
[65]  
Gao MQ(2016)Young JL, Spatz JP, In vitro cancer cell-ECM interactions inform in vivo cancer treatment Adv. Drug Deliv. Rev 97 145-2012
[66]  
Kim BG(2014)Takahiro Takakura, Nobuyuki, CD44 expressed on cancer-associated fibroblasts is a functional molecule supporting the stemness and drug resistance of malignant cancer cells in the tumor microenvironment Stem cells 32 376-2036
[67]  
Kang S(2017)Highmobilitygroup box 1 released by autophagic cancer-associatedfibroblasts maintains the stemness of luminal breast cancer cells J Pathol 243 1-16374
[68]  
Kim SH(2012)Fibroblast-secreted hepatocyte growth factor mediates epidermal growth factor receptor tyrosine kinase inhibitor resistance in triple-negative breast cancersthrough paracrine activation of Met Breast Cancer Res 14 4450-1055
[69]  
Cho NH(2014)IL-6 secreted bycancer-associated fibroblasts induces tamoxifen resistance in luminal breastcancer Oncogene 33 1955-1225
[70]  
Hu G(2006)Targeting tumorassociatedfibroblasts improves cancer chemotherapy by increasingintratumoral drug uptake J. Clin. Invest 116 6735-1924